Berg Pharma, LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Berg Pharma, LLC
Scrip Asks… What's The Current Climate For Deal-Making? (Part 2)
Following Gilead's acquisition of Kite, buzz grew that the deal might catalyze a surge in deal-making. Scrip asked a broad cross-section of biopharma insiders and observers about the deal-making environment – featured here are big pharma and industry experts.
Alzheimer's Prevention: The Next Big Idea For Fixing Drug Trial Failures
Mass screening of asymptomatic people is an expensive, daunting proposition, but very preliminary research with an amyloid beta blood test is spurring hope that a more practical way to identify those at risk will emerge in the future.
Pipeline Watch: Phase III Readouts For ADV7103, Pembrolizumab, Upadacitinib
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Deal Watch: Inventiva Expands Collaborations With Boehringer, AbbVie
French biotech expands fibrosis partnership with Boehringer Ingelheim, and a co-development pact with AbbVie around ROR gamma inverse agonists. Helsinn signs on to detail Novartis' Zykadia in the US.
- Digital Health
- Drug Discovery Tools
Drug Discovery Tools
- Other Names / Subsidiaries
- Berg Biosystems, LLC
- Berg Diagnostics, LLC
- Berg Health, LLC
- Cytotech Labs
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.